2010
DOI: 10.1039/b919840g
|View full text |Cite
|
Sign up to set email alerts
|

Controlled drug release from porous materials by plasma polymer deposition

Abstract: In this communication, we present a novel approach for control of drug release from porous materials. The method is based on deposition of a plasma polymer layer with controlled thickness which reduces a pore diameter and, hence, defines the rate of drug release.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
111
0
1

Year Published

2011
2011
2022
2022

Publication Types

Select...
7
3

Relationship

2
8

Authors

Journals

citations
Cited by 147 publications
(114 citation statements)
references
References 27 publications
2
111
0
1
Order By: Relevance
“…Indeed, porous silica lms with more disordered pore geometry had release half-lives close to two hours for negatively-charged uo-rescein isothiocyanate molecules. 6 In another study, the pore openings of NAA lms were reduced by plasma polymerization to less than 20 nm, which in turn extended release half-life to 100s of hours, 54 supporting the signicance of morphology on release kinetics and suggesting that the release half-life for np-Au thin lms can be further enhanced by tuning pore diameters via additional gold deposition and/or polymerization.…”
mentioning
confidence: 93%
“…Indeed, porous silica lms with more disordered pore geometry had release half-lives close to two hours for negatively-charged uo-rescein isothiocyanate molecules. 6 In another study, the pore openings of NAA lms were reduced by plasma polymerization to less than 20 nm, which in turn extended release half-life to 100s of hours, 54 supporting the signicance of morphology on release kinetics and suggesting that the release half-life for np-Au thin lms can be further enhanced by tuning pore diameters via additional gold deposition and/or polymerization.…”
mentioning
confidence: 93%
“…Controlling the pore diameters and lengths of TNTs by anodization process is used as a simple method to control drug re-lease characteristics, but this method has considerable limitation for applications where sustained drug release is required [16]. In our previous studies, we showed that the surface modification of pore structures via plasma polymerisation that allows control over pore diameter, has the potential to significantly improve drug delivery performance of porous and nanotubular materials [17][18][19][20]. Even, progress is encouraging; the development of new strategies able to provide sustained and controllable drug release is still required.…”
Section: Introductionmentioning
confidence: 99%
“…The study of plasma polymer coatings that could potentially be used in biomedical devices is an area of increasing research interest [1][2][3][4][5]. One of the most common classes of thin film treatments employed in biomaterial devices is that of 'low-fouling' or 'stealth' coatings [6].…”
Section: Introductionmentioning
confidence: 99%